Search Results - Jason Lickliter

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Cover Image

    A phase I randomized, double‐blinded, placebo‐controlled study assessing the safety and pharmacokinetics of RIPK1 inhibitor GFH312 in healthy subjects by Jason Lickliter, Shuang Wang, Wenxin Zhang, Huaqiang Zhu, Jing Wang, Congqiao Zhao, Haige Shen, Yu Wang

    Published 2023
    Connect to this object online.
    Book

    Save to List
    Saved in:
  2. 2
    Cover Image

    A first‐in‐human, randomized study of the safety, pharmacokinetics and pharmacodynamics of povetacicept, an enhanced dual BAFF/APRIL antagonist, in healthy adults by Rupert Davies, Stanford L. Peng, Jason Lickliter, Kristi McLendon, Amanda Enstrom, Allison G. Chunyk, Lori Blanchfield, NingXin Wang, Tiffany Blair, Heather M. Thomas, Alina Smith, Stacey R. Dillon

    Published 2024
    Connect to this object online.
    Book

    Save to List
    Saved in:
  3. 3
    Cover Image

    Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults by Susan B. Manoff, Michele Sausser, Amy Falk Russell, Jason Martin, David Radley, Donna Hyatt, Christine C. Roberts, Jason Lickliter, Janakan Krishnarajah, Andrew Bett, Sheri Dubey, Tyler Finn, Beth-Ann Coller

    Published 2019
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: